As of January 22, 2025, vTv Therapeutics (VTVT) has a market cap of $35.213 million USD. According to our data, vTv Therapeutics is ranked No.8349 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $35.21 M |
-2.38%
|
Dec 31, 2024 | $36.07 M |
20.08%
|
Dec 29, 2023 | $30.04 M |
-56.64%
|
Dec 30, 2022 | $69.28 M |
-33.37%
|
Dec 31, 2021 | $0.10 B |
-46.51%
|
Dec 31, 2020 | $0.19 B |
9.41%
|
Dec 31, 2019 | $0.18 B |
-35.85%
|
Dec 31, 2018 | $0.28 B |
-55.91%
|
Dec 29, 2017 | $0.63 B |
24.43%
|
Dec 30, 2016 | $0.50 B |
-29.07%
|
Dec 31, 2015 | $0.71 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
Market Cap | = | VTVT Stock Price | * | VTVT Shares Outstanding |
= | $13.48 | * | 2.61 M | |
= | $35.21 M |